AU2001256568A1 - New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them - Google Patents
New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- AU2001256568A1 AU2001256568A1 AU2001256568A AU5656801A AU2001256568A1 AU 2001256568 A1 AU2001256568 A1 AU 2001256568A1 AU 2001256568 A AU2001256568 A AU 2001256568A AU 5656801 A AU5656801 A AU 5656801A AU 2001256568 A1 AU2001256568 A1 AU 2001256568A1
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- new compounds
- anticancer activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN353/MAS/2000 | 2000-05-05 | ||
| IN353MA2000 | 2000-06-08 | ||
| IN435/MAS/2000 | 2000-06-08 | ||
| IN435MA2000 | 2000-06-08 | ||
| PCT/IB2001/000737 WO2001085709A2 (en) | 2000-05-05 | 2001-05-02 | New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001256568A1 true AU2001256568A1 (en) | 2001-11-20 |
Family
ID=26324891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001256568A Abandoned AU2001256568A1 (en) | 2000-05-05 | 2001-05-02 | New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001256568A1 (en) |
| WO (1) | WO2001085709A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7902359B2 (en) | 2006-12-11 | 2011-03-08 | Hutchison Medipharma Enterprises Limited | Decahydronaphthalene compounds |
| CN101591686B (en) * | 2009-06-23 | 2011-08-31 | 南京农业大学 | Method for preparing andrographolide esterfied derivatives through biocatalysis |
| CN103145665B (en) * | 2012-04-12 | 2014-12-31 | 江西青峰药业有限公司 | 17-hydro-9-dehydro-14,17-cyclo-andrographolide-19-sulphate and its preparation method and use in drug preparation |
| WO2017088738A1 (en) * | 2015-11-26 | 2017-06-01 | 南京明德新药研发股份有限公司 | Modified compound of andrographolide |
| CN106800551B (en) * | 2015-11-26 | 2021-05-11 | 黑龙江珍宝岛药业股份有限公司 | Andrographolide modified compound |
| CN105541766B (en) * | 2015-12-16 | 2018-08-24 | 四川理工学院 | The andrographolidume derivative of a kind of sulfur-bearing, its pharmaceutical composition, synthetic method and purposes |
| CN108484543B (en) * | 2018-03-23 | 2020-11-03 | 海南长春花药业有限公司 | Preparation method of potassium dehydroandrographolide succinate or potassium dehydroandrographolide succinate |
| CN109912583A (en) * | 2019-04-03 | 2019-06-21 | 四川轻化工大学 | A kind of 3,19 cyclic sulfur-bearing andrographolidume derivatives, its pharmaceutical composition, synthetic method and purposes |
| CN112645937B (en) * | 2020-12-28 | 2022-05-31 | 深圳湾实验室 | Aza spiro ring and polycyclic andrographolide compound, preparation method thereof, pharmaceutical composition and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6388124A (en) * | 1986-09-30 | 1988-04-19 | Toyo Jozo Co Ltd | Antitumor agent |
| AU4376396A (en) * | 1994-12-06 | 1996-06-26 | Paracelsian, Inc. | Use of andrographolide compounds to treat or prevent pathogenicity of diseases |
| US5833994A (en) * | 1997-01-08 | 1998-11-10 | Paracelsian, Inc. | Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection |
-
2001
- 2001-05-02 WO PCT/IB2001/000737 patent/WO2001085709A2/en active Application Filing
- 2001-05-02 AU AU2001256568A patent/AU2001256568A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085709A3 (en) | 2002-05-30 |
| WO2001085709A2 (en) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0204110A3 (en) | Amphiphilic prodrugs, process for preparation and use of pharmaceutical compositions containing them | |
| HUP0203107A3 (en) | Novel spiro compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203316A3 (en) | Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0301187A3 (en) | Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203136A3 (en) | Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203548A3 (en) | New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0201516A2 (en) | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AU2001258677A1 (en) | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them | |
| HUP0201753A2 (en) | Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201206A2 (en) | Antibacterial compounds, process for their preparation and pharmaceutical compositions containing them | |
| AP2002002575A0 (en) | Compounds having hypolupedemic and hypocholestermic activities process for their preparation and pharmaceutical compositions containing them | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203184A3 (en) | Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204347A3 (en) | Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0400926A3 (en) | Lipid lowering new biphenylcarboxamides, process for their preparation and pharmaceutical compositions containing them | |
| AU2001256570A1 (en) | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them | |
| HUP0202731A3 (en) | O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HU0100489D0 (en) | New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0302515A3 (en) | Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
| AU2001256568A1 (en) | New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them | |
| HUP0301254A3 (en) | Novel compounds, process fo their preparation and pharmaceutical compositions containing them | |
| HUP0302905A3 (en) | Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them | |
| AU5525199A (en) | N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |